David Yadin, Principal Scientist at Alchemab Therapeutics Ltd

David Yadin

Principal Scientist at Alchemab Therapeutics Ltd | Cambridge, England, United Kingdom

Profile last verified July 2026
Research Verified Profile Cambridge, England, United Kingdom University of Oxford
Verified

Work Email

***@alchemab.com

Last verified August 2026

Personal Email

***@gmail.com

Personal • High Confidence

Phone Number

+44 ** **** *313

United Kingdom • Phone

Free account · No credit card · 5 profiles/month

David Yadin Socials
David Yadin Work Experience

Principal Scientist at Alchemab Therapeutics Ltd in January 2023 - Present

Senior Scientist at Alchemab Therapeutics Ltd in May 2021 - December 2022

Research Scientist 2 at Kymab Ltd in July 2018 - May 2021

See more See less

Senior Scientist I at Crescendo Biologics Limited in March 2018 - July 2018

Research Scientist at Crescendo Biologics Limited in February 2017 - February 2018

Postdoctoral Fellow at Berlin-Brandenburg School for Regenerative Therapies in November 2013 - January 2017

Post-doctoral research associate at Department of Biochemistry, University of Oxford, UK in November 2012 - April 2013

David Yadin Education

University of Oxford, January 2004 to January 2008

About David Yadin’s Current Company
Alchemab Therapeutics Ltd

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development. Alchemab takes an unbiased and function-first approach using three complementary processes and cutting-edge technologies to identify naturally protective antibodies. Alchemab’s engine is enabled through collaborations with patient representative groups and biobanks around the world with whom we partner to further our understanding of disease.

Discover more about Alchemab Therapeutics Ltd
David Yadin’s Colleagues
Donna Finch

Donna Finch

Greater Cambridge Area

Head of Translational and Clinical Sciences at Alchemab Therapeutics Ltd

Head of Translational and Clinical Sciences at Alchemab Therapeutics Ltd
(April 2020 – Present)

Amparo Navasa

Amparo Navasa

London, England, United Kingdom

Bioinformatician | Antibody discovery | Target Deconvolution | Drug Discovery | PhD in Immunology (Crick/UCL)

Senior Bioinformatician, Antibody Discovery and Target Deconvolution at Alchemab Therapeutics Ltd
(January 2024 – Present)

Anna Czyz

Anna Czyz

Greater Cambridge Area

Protein Scientist

Protein Scientist at Alchemab Therapeutics Ltd
(September 2021 – Present)

Ashley Mason

Ashley Mason

Greater Boston

Neuroscience | Cell Biology

Scientist, Neuroscience at Alchemab Therapeutics Ltd
(June 2023 – Present)

Brad Holub

Brad Holub

Harvard, Massachusetts, United States

Scientist and Manager at Alchemab Therapeutics Ltd

Scientist and Manager at Alchemab Therapeutics Ltd
(September 2021 – Present)

April Woulfe

April Woulfe

Greater Cambridge Area

Protein Scientist

Scientist at Alchemab Therapeutics Ltd
(March 2022 – Present)

Search similar profiles
Frequently asked questions about David Yadin

What is David Yadin email address?

Email David Yadin at [email protected] and [email protected]. This email is the most updated David Yadin's email found in 2026.

How to contact David Yadin?

To contact David Yadin send an email to [email protected] or [email protected].

What company does David Yadin work for?

David Yadin works for Alchemab Therapeutics Ltd.

What is David Yadin's role at Alchemab Therapeutics Ltd?

David Yadin is Principal Scientist

What industry does David Yadin work in?

David Yadin works in the Research industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free